Escolar Documentos
Profissional Documentos
Cultura Documentos
Search
News Front Page World UK England Northern Ireland Scotland Wales Business Politics Health Medical notes Education Science & Environment Technology Entertainment Also in the news ----------------Video and Audio ----------------Have Your Say Magazine In Pictures Country Profiles Special Reports
RELATED BBC SITES
Arthritis drug access 'a lottery' 13 Oct 06 | Health Go-ahead for NHS arthritis drugs 22 Mar 02 | Health Arthritis patients denied drugs 06 Jun 05 | Health Arthritis 11 Apr 03 | Medical notes
RELATED INTERNET LINKS
Activity among the first group improved by 20-25%, according to results presented at the annual Eular meeting. The number of joints causing pain or discomfort fell by 40%, but did not change for those treated with the dummy. "I think we were all surprised to see such meaningful results," said Professor Stefan Willich from the Charite University Medical Centre in Berlin, who conducted the German arm of the study. "Rheumatoid arthritis is one of the most difficult conditions I'm aware of. It's a tough disease, which makes it all the more remarkable to find such beneficial effects from this remedy." Experts now want to conduct more extensive trials to see if the results are confirmed. Saving money An estimated 400,000 people in the UK suffer from rheumatoid arthritis, a potentially crippling condition which occurs when the immune system attacks the joints. It causes swelling and damage of cartilage and bone.
One idea is that it might be possible to postpone the day that you need the expensive medicines
Eular Arthritis Research Campaign Rheumatology The BBC is not responsible for the content of external internet sites
TOP HEALTH STORIES
Hospitals 'eyeing private market' Stem cell method put to the test Stem cell 'hope' for arthritis
| News feeds
MOST POPULAR STORIES NOW MOST SHARED MOST READ
National public pay rate 'to end' 'Nazi guard' John Demjanjuk dies When governments choose to assassinate Kony 2012 video director detained St Patrick's parade for Duchess Early bloom causes daffodil clash Reagan's 'torso' doodle released Apple factory radio show 'lied' Thatcher 'met Murdoch in secret' 'Trophy' rapist special PC jailed Most popular now, in detail
Anti-TNF (anti-tumour necrosis factor alpha) medication and the latest "smart" drugs which Professor Kaj Winther target different parts of the immune system are becoming available, but they are expensive, and there have already been complaints of "postcode lottery" access.
One month's supply of the LitoZin supplement costs around 20. It is already available at high-street chemists as it is widely used by patients with osteo-arthritis, a less debilitating condition caused by general wear and tear. Researchers are unclear as to why exactly rose-hip has this effect, but the supplement appears to have both antiinflammatory and anti-oxidant properties. One of the key active ingredients in LitoZin - a type of sugary fatty acid called GOPO - was hailed by scientists involved in the research as a "plant version of fish oil", the supplement believed to have a host of health benefits. Professor Kaj Winther, who ran the Danish part of the study, said the supplement could be used as an interim treatment to postpone the day the patient needed to move on to the more expensive drugs. Professor Alan Silman, the medical director of the Arthritis Research Campaign, said that if rose-hips were shown to have only limited side effects they could be a useful adjunct to conventional drug treatment for people with rheumatoid arthritis.
However, he added that the results of the study had to be treated with some caution as the patients were given rose-hip extract to supplement their normal therapy. Larger studies over a longer period were needed for the results of the small study to be confirmed, he said.
Printable version
The most read story in Europe is: Mona Lisa 'had high cholesterol'
E-mail news
Mobiles
Alerts
News feeds
Interactive TV
Help
News sources
Contact us